Worth Watching Stock: Geopark Ltd(NYSE:GPRK): Arcus Biosciences, Inc.(NYSE:RCUS)

0
0

Geopark Ltd (GPRK) will report its next earnings on Aug 05 AMC. The company reported the earnings of $-0.33/Share in the last quarter where the estimated EPS by analysts was $-0.5/share. The difference between the expected and actual EPS was $0.17/share, which represents an Earnings surprise of 34%.

Many analysts are providing their Estimated Earnings analysis for Geopark Ltd and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $0.19/share. These analysts have also projected a Low Estimate of $0.19/share and a High Estimate of $0.19/share.

In case of Revenue Estimates, 1 analysts have provided their consensus Average Revenue Estimates for Geopark Ltd as 26.5 Million. According to these analysts, the Low Revenue Estimate for Geopark Ltd is 26.5 Million and the High Revenue Estimate is 26.5 Million. The company had Year Ago Sales of 151.2 Million.

Some buy side analysts are also providing their Analysis on Geopark Ltd, where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.66 and Average Volume (3 months) is 257.53 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 19.43.

The company shows its Return on Assets (ROA) value of -5.7%. The Return on Equity (ROE) value stands at -47%. While it’s Return on Investment (ROI) value is 17%.

While looking at the Stock’s Performance, Geopark Ltd currently shows a Weekly Performance of 5.02%, where Monthly Performance is 8.57%, Quarterly performance is 46.15%, 6 Months performance is -48.44% and yearly performance percentage is -37.87%. Year to Date performance value (YTD perf) value is -53.39%. The Stock currently has a Weekly Volatility of 4.50% and Monthly Volatility of 4.94%.

Arcus Biosciences, Inc. (RCUS) will report its next earnings on 0. The company reported the earnings of $-0.93/Share in the last quarter where the estimated EPS by analysts was $-0.61/share. The difference between the expected and actual EPS was $-0.32/share, which represents an Earnings surprise of -52.5%.

Many analysts are providing their Estimated Earnings analysis for Arcus Biosciences, Inc. and for the current quarter 9 analysts have projected that the stock could give an Average Earnings estimate of $-0.01/share. These analysts have also projected a Low Estimate of $-0.69/share and a High Estimate of $2.07/share.

In case of Revenue Estimates, 8 analysts have provided their consensus Average Revenue Estimates for Arcus Biosciences, Inc. as 48.17 Million. According to these analysts, the Low Revenue Estimate for Arcus Biosciences, Inc. is 1.2 Million and the High Revenue Estimate is 182.7 Million. The company had Year Ago Sales of 1.75 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for RCUS to be 286.3%. They are projecting Next Quarter growth of -23.68%. For the next 5 years, Arcus Biosciences, Inc. is expecting Growth of 47.71% per annum, whereas in the past 5 years the growth was 26.42% per annum.

Some buy side analysts are also providing their Analysis on Arcus Biosciences, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.86 and Average Volume (3 months) is 801.79 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is -54.2%.

While looking at the Stock’s Performance, Arcus Biosciences, Inc. currently shows a Weekly Performance of 16.31%, where Monthly Performance is 5.77%, Quarterly performance is -20.25%, 6 Months performance is 119.72% and yearly performance percentage is 234.32%. Year to Date performance value (YTD perf) value is 144.95%. The Stock currently has a Weekly Volatility of 6.16% and Monthly Volatility of 5.76%.

SHARE